Intraosseous Infusion Devices Market Analysis & Forecast: 2025-2032

Intraosseous Infusion Devices Market is estimated to be valued at USD 1,112.1 Mn in 2025 and is expected to reach USD 1,607.0 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.4% from 2025 to 2032.

Analysts’ Views on Global Intraosseous Infusion Devices Market:

Intraosseous infusion is advised for cardiopulmonary resuscitation when peripheral venous access fails, which is projected to boost the global intraosseous infusion device market over the forecast period. Thh intraosseous infusion device market is rapidly increasing, owing to an increase in emergency care cases and the prevalence of chronic conditions such as severe accidents, cardiovascular ailments, obesity, and serious burns, which fuel the hospitalization chances.

Figure 1. Global Intraosseous Infusion Devices Market Share (%), By Product Type, 2025

To learn more about this report, Request sample copy

Global Intraosseous Infusion Devices Market– Drivers

• Increasing prevalence of cardiovascular disorders: Increasing incidence of cardiovascular disorders is anticipated to drive the market growth during the forecast period. For instance, in 2022, according to the American Heart Association report titled Heart and Stroke Statistics 2022 Update, more than 356,000 out-of-hospital cardiac arrests (OHCA) are reported annually in the U.S., nearly 90% of the them were fatal. The incidence of EMS-assessed non-traumatic OHCA in people of any age is estimated to 356,461, or nearly 1,000 people each day. Survival to hospital discharge after EMS-treated cardiac arrest languishes at about 10%.
• Increasing technologically advanced product launches and approvals: Increasing launches of advanced products is expected to drive the market growth during the forecast period. For instance, in March 2022, PAVmed Inc., a diversified commercial stage medical technology company, announced that physicans at the Clinica Porto Azul in Barranquilla, Columbia, successfully implanted the company’s PORTIO Intraosseous Infusion System in three patients-the first human implants of the device-as part of its IRB-approved first-in-human (FIH) clinical study of upto 40 patients.  

Figure 2. Global Intraosseous Infusion Devices Market Share(%), By Region, 2025

To learn more about this report, Request sample copy

Global Intraosseous Infusion Devices Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global intraosseous infusion devices market over the forecast period. North America is estimated to hold 33.5 % of the market share in 2025. The global intraosseous infusion devices market is expected to witness significant growth in the near future due to high prevalence of cardiovasular disorders, favorable health reimbursement, and increased awareness. Increasing prevalence of cancer is contributing to growth of the intraosseous infusion devices market in North America region. For instance, in 2022,  according to the National Center of Health Statistics, 1,918,030 new cancer cases and 609,360 cancer deathsare projected to occur in the U.S., which includes around 350 deaths per day from lung cancer, the leading cause of cancer deaths in 2023. This is expected to increase the number of chemotherapies in the U.S., thereby, boosting demand for intraosseous infusion devices in the U.S.

Global Intraosseous Infusion Devices Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding transportation of things from one place to another.

The coronavirus or COVID-19 outbreak that started from Wuhan, China, has spread across continents, affecting various industries globally. Supply of key materials has been severely disrupted due to the forced quarantine, and lack of labor and raw materials. As the link between regional warehouses is not smooth, the transportation of raw materials between regions cannot be carried out successfully. This shortage of raw materials and components have affected the supply chain of the global intraosseous infusion devices market.

Moreover, the COVID-19 pandemic has impacted the global economy and in turn, the global intraosseous infusion devices market positively. Quarantines, traveling constraints, and social distancing measures are likely to lead to a steep decline in business and consumer spending. 

Global Intraosseous Infusion Devices Market- Segmentation:

Global intraosseous infusion devices market report is segmented into by product type, by technology, by end user, and by region.

• By Product Type, the market is segmented into FAST 1 Device, FAST x Device, Bone Injection Gun (BIG) Devices, EZ-IO Device, NIO Device, Dieckmann Modified Needle, and Jamshidi Needle. Out of which, the FAST 1 device segment is expected to hold a dominant position in the global intraosseous infusion devices market during the forecast period due to growing cases of cardiopulmonary resuscitation (CPR) procedures.
• By Technology, the market is segmented into Manual IO Needles, battery powered driver, and impact driven devices. Out of which, Manual IO Needles segment is expected to dominate the market over the forecast period due to increasing tibia and fibula fractures.
• By End User, the market is segmented into hospitals, clinics, ambulatory surgical centers, and others. Out of which,  hospitals segment is expected to dominate the market over the forecast period as prompt treatment in hospital that can lead to proper recovery.

Among all the segmentation, the product type segment is expected to dominate the market over the forecast period due to increasing usage FAST 1 Intraosseous Infusion Devices by physicians.

Global Intraosseous Infusion Devices Market- Cross Sectional Analysis:

Key players are manufacturing intraosseous infusion devices with advanced technology in emerging economies owing to growing incidences of cardiovascular diseases and road accidents, which is driving the overall intraosseous infusion devices market across North America. For instance, in 2022, according to the data published by MedScape, in U.S., the incidence of femoral shaft fractures ranges from 9.5 to 18.9 per 100,000 annually. Moreover, approximately 250,000 proximal femur fractures occur in the U.S. annually.  

Global Intraosseous Infusion Devices Market: Key Developments

In June 2023, Teleflex Incorporated, a global provider of medical technologies, received U.S. FDA 510(k) clearance for its Arrow EZ-1O needle for MR conditional labelling. The EZ-IO needle represents a critical component of Teleflex’s Arrow EZ-IO intraosseous vascular access system. It features a patented diamond tip for fast, precise and steady insertion. The system can be used when intravenous access is difficult or impossible to obtain in emergent, urgent or medically necessary cases.

Global Intraosseous Infusion Devices Market: Key Trends

• Introduction of Intraosseous Infusion Devices with advanced technology: Introduction of Intraosseous Infusion Devices with trending technologies in the market is expected to drive growth of the global intraosseous infusion devices market over the forecast period. For instance, the FASTx intraosseous infusion device provides a sternal intraosseous access route to patients when standard venous access is not possible. By using the sternal IO access route, providers can rapidly deliver lifesaving fluids and medications1-3 to facilitate emergency resuscitation through the bone marrow space. FASTx can be effectively used during CPR and when a cervical spine collar is in place.

Global Intraosseous Infusion Devices Market: Restraint

• Restriction for the Patients Suffering from Osteoporosis: The intraosseous infusion devices are difficult to insert into soft tissues that leads to compartment syndrome. This factor is steadily hindering growth rate of the global intraosseous infusion device market. The patient who have osteoporosis are restricted to use these devices, and this also hampers the global intraosseous infusion device market growth. Key players focusing on developing advance products with safety and cost effective which is expected to drive the market growth over the forecast period.

Global Intraosseous Infusion Devices Market - Key Players

Major players operating in the global intraosseous infusion devices market include PerSys Medical, Aero Healthcare AU Pty Ltd, Teleflex Incorporated, PAVmed Inc., Becton Dickinson Company, BIOPSYBELL S.R.L., Cook Group, SAM Medical, Argon Medical Devices, Inc., Cardinal Health, Inc., StarFish Product Engineering Inc., and Medax SRL unipersonle.

Definition: Intraosseous (IO) infusion involves injecting medication and fluids directly into the marrow of the bone by which rapid access to the vascular system can be gained. Intraosseous infusion offers several benefits when intravenous (IV) access is not possible and rapid vascular access is necessary.